Search

Your search keyword '"Longo J"' showing total 596 results

Search Constraints

Start Over You searched for: Author "Longo J" Remove constraint Author: "Longo J"
596 results on '"Longo J"'

Search Results

53. THU0282 The impact of comorbidities on physical function in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PSA) attending rheumatology clinics

61. Maghemite–gold core–shell nanostructures (γ-Fe2O3@Au) surface-functionalized with aluminium phthalocyanine for multi-task imaging and therapy

62. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

63. A cross sectional evaluation of an alcohol intervention targeting young university students

67. Consequences of Low Risk and Hazardous Alcohol Consumption among University Students in Australia and Implications for Health Promotion Interventions

71. Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis

72. FRI0619-HPR Joint Prostheses and Biologic Therapies in a Rheumatologic Clinic

75. Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case–control study

76. Reflections on Conditions for Commericail Air-launched Suborbital Flight in Europe - Selected Results of a Study Funded by the European Community (EC)

80. The Sharp Edge Flight Experiment SHEFEX I - A Mission Overview

85. AB0396 Infliximab and Adalimumab Levels and Antidrug Antibodies Detection in Patients with Rheumatoid Arthritis (RA): an Interlaboratory Comparison Using A Commercial ELISA Assay

86. SAT0340 Infliximab Levels and Anti-Infliximab Antibodies Comparison between Two Comercial ELISA Versions in Patients with Ankylosing Spondylitis

87. THU0250 Predictive Value of Doppler Ultrasound-Detected Synovitis in Relation to Successful Tapering of Biology Therapy in Patients with Rheumatoid Arthritis

88. SAT0318 Antisynthetase Syndrome: Clinical and Serological Characteristics at Disease Onset: Table 1.

89. AB0398 Relation between Serum Infliximab Levels and Changes of Rheumatoid Factor and Antibodies to Citrullinated Peptides Levels in Patients with Rheumatoid Arthritis

90. AB0434 Relation of Subclinical Ultrasound Detected Synovitis and Peripheral B-Cell Counts in Rheumatoid Arthritis Patients Treated with Rituximab

91. AB0027 B-Cell Activating Factor (BAFF) Binding Receptors (BBR) on B Cells: Characterization in Patients with Rheumatoid Arthritis (RA) Receiving Biological Therapies: Anti-TNF, Anti-Il6r and Anti-Ctla4: A Longitudinal Study

92. THU0585-HPR Impact on the Therapeutic Response to Anti-Tumor Necrosis Factor (ANTI-TNF) Agents of the Thickness of the Subcutaneous Tissue (SBC) in the Site of Injection Measured by Ultrasound

93. AB0026 B-Cell Profile in RA Patients Treated with Two Different Biological Therapeutic Targets: Anti-TNF and Anti-Il6r. A Cross-Sectional Study

94. THU0187 Does Ultrasound-Scored Synovitis Depend on the Pharmacokinetics of Subcutaneous Anti-TNF Agents in Patients with Rheumatoid Arthritis?: Table 1.

95. Investigation of the Reaction 12C(e, e'ppi-)11C

96. The Sharp Edge Flight Experiment SHEFEX

97. Arbeitspakete Aerothermodynamik

98. Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography

99. AB0041 B-cell activating factor (BAFF) binding receptors (BBR) on B cells: characterization in patients with rheumatoid arthritis (RA) receiving anti-TNF-alpha agent infliximab (IFX)

100. THU0215 Establishing Cut-Off of Infliximab and Anti-Infliximab Antibody Levels Using a Commercial Elisa in Patients with Rheumatoid Arthritis

Catalog

Books, media, physical & digital resources